PFIZER INC | 2013 | FY | 3


The following table provides the assets acquired and liabilities assumed from King: 
(MILLIONS OF DOLLARS)
 
Amounts
Recognized as of
Acquisition Date(a)


Working capital, excluding inventories
 
$
155

Inventories
 
340

Property, plant and equipment
 
412

Identifiable intangible assets, excluding in-process research and development
 
1,806

In-process research and development
 
303

Net tax accounts
 
(328
)
All other long-term assets and liabilities, net
 
102

Total identifiable net assets
 
2,790

Goodwill(b)
 
765

Net assets acquired/total consideration transferred
 
$
3,555

(a) 
Includes animal health-related assets and liabilities. In 2013, we disposed of our Animal Health business. For additional information, see Notes to Consolidated Financial Statements—Note 2B. Acquisitions, Divestitures, Collaborative Arrangements and Equity-Method Investments: Divestitures.
(b) 
Goodwill recorded as of the acquisition date totaled $720 million for our three biopharmaceutical operating segments and $45 million for our Animal Health operating segment. (Since the acquisition of King, we have revised our operating segments and disposed of our Animal Health business.)

us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock